TopNews United States
US Advisory Committee to Re-evaluate Vivus's Weight Loss Drug in July
TopNews United States
Another one in the queue of manufacturing weight loss drug is Orexigen Therapeutics which intends to file for FDA approval by April.
RxNews Recap for Friday 03-26-10BioMedReports (subscription) (blog)
Vivus obesity drug to see US panel review in JulyReuters
A New Drug to Fight ObesityMainStreet
Wall Street Journal -Minyanville.com
all 41 news articles »

Original post click here

Comments are closed.


Content Protected Using Blog Protector By: PcDrome.